MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1793-1797

  Permuth Wey, Jennifer ^a   Chen, Zhihua ^a   Tsai, Ya Yu ^a   Lin, Hui Yi ^a   Chen, Y Ann ^a   Barnholtz Sloan, Jill ^c   Birrer, Michael J ^d   Chanock, Stephen J ^f   Cramer, Daniel W ^e   Cunningham, Julie M ^g   Fenstermacher, David ^a   Fridley, Brooke L ^g   Garcia Closas, Montserrat ^o   Gayther, Simon A ^k   Gentry Maharaj, Aleksandra ^p   Gonzalez Bosquet, Jesus ^a   Iversen, Edwin ⁱ   Jim, Heather ^a   McLaughlin, John ^l   Menon, Usha ^p   Narod, Steven A ^m   Phelan, Catherine M ^a   Ramus, Susan J ^k   Risch, Harvey ^j   Song, Honglin ⁿ   Sutphen, Rebecca ^b   Terry, Kathryn L ^e   Tyrer, Jonathan ⁿ   Vierkant, Robert A ^g   Wentzensen, Nicolas ^f   Lancaster, Johnathan M ^a   Cheng, Jin Q ^a   Berchuck, Andrew ^h   Pharoah, Paul D P ⁿ   Schildkraut, Joellen M ^h   Goode, Ellen L ^g   Sellers, Thomas A ^q   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g Mayo Clinic College of Medicine   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Duke University   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l MOUNT SINAI HOSPITAL   (Canada)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^o INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEAD BOX PROTEIN 20; EXPORTIN 5; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; K RAS PROTEIN; MICRORNA; TRANSCRIPTION FACTOR E2F2;

ALLELE; ARTICLE; BINDING SITE; BIOGENESIS; CANCER RISK; CONTROLLED STUDY; EPITHELIUM TUMOR; EUROPE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RNA PROCESSING; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STRATIFIED SAMPLE;

BINDING SITES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79961241800     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0397     Document Type: Article

References (12)

1. Li SD, Zhang JR, Wang YQ, Wan XP. The role of microRNAs in ovarian cancer initiation and progression. J Cell Mol Med 2010;14:2240-9.
2. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010;10:389-402.
3. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 2010;70:9765-76.
4. Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 2011;71:3896-903.
5. Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Adv Exp Med Biol 2008;622:53-67.
6. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009;41:996-1000.
7. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37:W600-5. Available from: http://manticore.niehs.nih.gov/ [accessed Feb 2011].
8. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, et al. PolymiRTS database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 2007;35:D51-4. Available from: http://compbio.uthsc.edu/ miRSNP.
9. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9. (Pubitemid 44141658)
10. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75. Available from: http://pngu.mgh. harvard.edu/~purcell/plink/ [accessedFeb2011].
11. Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver HA, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011;17:3742-50.
12. Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res 2010;70:6509-15.